BAC
48
10
RIG
41
4
ALLE
48
7
HCP
82
-2
AAP
29
2
MSFT
57
2
NSC
40
3
UA
33
4
AAL
39
3
GME
74
12
EMN
72
3
WY
36
5
DHI
48
3
AMGN
57
2
GOOGL
72
5
SYY
50
2
AZO
48
2
SPG
50
2
MDLZ
48
-17
HOG
33
6
BAC
48
10
RIG
41
4
ALLE
48
7
HCP
82
-2
AAP
29
2
MSFT
57
2
NSC
40
3
UA
33
4
AAL
39
3
GME
74
12
EMN
72
3
WY
36
5
DHI
48
3
AMGN
57
2
GOOGL
72
5
SYY
50
2
AZO
48
2
SPG
50
2
MDLZ
48
-17
HOG
33
6
Financhill
Back

SCYNEXIS Quote, Financials, Valuation and Earnings

This trade could move overnight Thursday!

Access my free presentation on these overnight trades right here
Buy
75

SCYX
SCYNEXIS

Last Price:
1.78
Seasonality Move:
-11.54%

7 Day Trial

ALL ACCESS PASS

$ 7

Elon's Secret "A.I. 2.0" Project

Click here now to discover how to claim a stake in Elon's "A.I. 2.0" project

SCYNEXIS Price Quote

$1.78

SCYNEXIS Key Stats

Buy
75
SCYNEXIS (SCYX) is a Buy
Day range:
$1.70 - $1.79
52-week range:
$1.35 - $3.87
Dividend yield:
0%
P/E ratio:
1.28
P/S ratio:
0.61
P/B ratio:
0.92%
Volume:
120.8K
Avg. volume:
186.9K
1-year change:
-41.64%
Market cap:
$67.2M
Revenue:
$140.1M
EPS:
$1.3

How Much Does SCYNEXIS Make?

  • How Much Are SCYNEXIS's Sales Annually?
    SCYX Revenues are $140.1M
  • How Much Profit Does SCYNEXIS's Make A Year?
    SCYX net income is $67M

Is SCYNEXIS Growing As A Company?

  • What Is SCYNEXIS's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 2.8%
  • What Is SCYNEXIS's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

SCYNEXIS Stock Price Performance

  • Did SCYNEXIS Stock Go Up Last Month?
    SCYNEXIS share price went up by 22.76% last month
  • Did SCYX's Share Price Rise Over The Last Year?
    SCYX share price fell by -41.64% over the past 1 year

What Is SCYNEXIS 52-Week High & Low?

  • What Is SCYNEXIS’s 52-Week High Share Price?
    SCYNEXIS has traded as high as $3.87 over the past 52 weeks
  • What Is SCYNEXIS’s 52-Week Low Share Price?
    SCYNEXIS has traded as low as $1.35 over the past 52 weeks

SCYNEXIS Price To Free Cash Flow

  • Is SCYNEXIS Stock Overvalued?
    SCYNEXIS is trading at a price to free cash flow ratio of 1.43
  • Is SCYNEXIS Stock Undervalued?
    SCYNEXIS EV to Free Cash Flow ratio is 0.08
  • What Is SCYNEXIS’s Price Earnings Growth Ratio?
    SCYX PEG ratio is 0.00
  • Is SCYNEXIS Trading At A Premium To Earnings?
    SCYNEXIS EV to EBIT ratio is 0.07

Is It Risky To Buy SCYNEXIS?

  • How Much Debt Does SCYNEXIS Have?
    Total long term debt quarterly is $12.2M
  • How Much Cash Does SCYNEXIS Have?
    Cash and short term investments quarterly total is $74.4M
  • What Is SCYNEXIS’s Book Value Per Share?
    Book value per share is 1.96

Is SCYNEXIS Cash Flow Positive?

  • What Is SCYX Cash Flow From Operations?
    Cash flow from operations (TTM) is $60.2M
  • What Is SCYNEXIS’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$36.7M
  • What Is SCYNEXIS’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$34.9M

SCYNEXIS Return On Invested Capital

  • Is Management Doing A Good Job?
    SCYX return on invested capital is 93.53%
  • What Is SCYNEXIS Return On Assets?
    ROA measures how assets are converting to revenues and is 56.82%
  • What Is SCYX Return On Equity?
    ROE is a measure of profitability and is 144.89%

SCYNEXIS Earnings Date & Stock Price

  • What Is SCYNEXIS's Stock Price Today?
    A single share of SCYX can be purchased today for 1.78
  • What Is SCYNEXIS’s Stock Symbol?
    SCYNEXIS trades on the nasdaq under the ticker symbol: SCYX
  • When Is SCYNEXIS’s Next Earnings Date?
    The next quarterly earnings date for SCYNEXIS is scheduled on May 10, 2024
  • When Is SCYX's next ex-dividend date?
    SCYNEXIS's next ex-dividend date is May 3, 2024
  • How To Buy SCYNEXIS Stock?
    You can buy SCYNEXIS shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

SCYNEXIS Competitors

  • Who Are SCYNEXIS's Competitors?
    Below is a list of companies who compete with SCYNEXIS or are related in some way:
    • iBio Inc (IBIO)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Oragenics Inc (OGEN)
    • Palatin Technologies Inc (PTN)
    • Theriva Biologics Inc (TOVX)

SCYNEXIS Dividend Yield

Data Unavailable

SCYNEXIS Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -437.93%
Revenue: 280.38% -24.2%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 6.88
Upside from Last Price: 286.24%

Major Shareholders

  • How many SCYX shares are owned by institutional investors?
    44.3M SCYX shares are owned by institutional investors
  • How many SCYX shares are owned by insiders?
    1.7M SCYX shares are owned by insiders